Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241411683 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Maria Anna Papadopoulou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Medical School, University of Crete, 71003 Heraklion, Greece. Hauptthemen laut MEDLINE: Receptor, Nerve Growth Factor, Nerve Growth Factors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the European Union's Horizon 2020 research and innovation programme "Euroneurotrophin" under the Marie Skłodowska-Curie grant agreement, the Hellenic Foundation for Research and Innovation (H.F.R.I) under the "1st Call for H.F.R.I. Research Projects to support Faculty members and Researchers and…, co-financed by Greece and the European Union (European Social Fund-ESF) through the Operational Programme «Human Resources Development, Education and Lifelong….
Abstract (Originalsprache)
Neuronal cell fate is predominantly controlled based on the effects of growth factors, such as neurotrophins, and the activation of a variety of signaling pathways acting through neurotrophin receptors, namely Trk and p75 (p75NTR). Despite their beneficial effects on brain function, their therapeutic use is compromised due to their polypeptidic nature and blood–brain-barrier impermeability. To overcome these limitations, our previous studies have proven that DHEA-derived synthetic analogs can act like neurotrophins, as they lack endocrine side effects. The present study focuses on the biological characterization of a newly synthesized analog, ENT-A044, and its role in inducing cell-specific functions of p75NTR. We show that ENT-A044 can induce cell death and phosphorylation of JNK protein by activating p75NTR. Additionally, ENT-A044 can induce the phosphorylation of TrkB receptor, indicating that our molecule can activate both neurotrophin receptors, enabling the protection of neuronal populations that express both receptors. Furthermore, the present study demonstrates, for the first time, the expression of p75NTR in human-induced Pluripotent Stem Cells-derived Neural Progenitor Cells (hiPSC-derived NPCs) and receptor-dependent cell death induced via ENT-A044 treatment. In conclusion, ENT-A044 is proposed as a lead molecule for the development of novel pharmacological agents, providing new therapeutic approaches and research tools, by controlling p75NTR actions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Medical School, University of Crete, 71003 Heraklion, Greece.
- Institute of Molecular Biology & Biotechnology (IMBB), Foundation for Research and Technology-Hellas (FORTH), 70013 Heraklion, Greece.
ORCID-Profile: Maria Anna Papadopoulou, Thanasis Rogdakis, Achille Gravanis, Konstantina Chanoumidou, Ioannis Charalampopoulos
Förderung
- the European Union's Horizon 2020 research and innovation programme "Euroneurotrophin" under the Marie Skłodowska-Curie grant agreement
- the Hellenic Foundation for Research and Innovation (H.F.R.I) under the "1st Call for H.F.R.I. Research Projects to support Faculty members and Researchers and…
- co-financed by Greece and the European Union (European Social Fund-ESF) through the Operational Programme «Human Resources Development, Education and Lifelong…
- the national Flagship Action "Hellenic Precision Medicine Network in Neurodegenerative Diseases", funded by the Ministry of Development and Investment and the…
- European Union’s Horizon
- Hellenic Foundation
- Greece and the European Union (European Social Fund-ESF)
- Ministry of Development and Investment and the General Secretariat for Research and Innovation (GSRI)
Zitieren
APA
Papadopoulou, M. A., Rogdakis, T., Charou, D., Peteinareli, M., Ntarntani, K., Gravanis, A., Chanoumidou, K., & Charalampopoulos, I. (2023). Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411683
Vancouver
Papadopoulou MA, Rogdakis T, Charou D, Peteinareli M, Ntarntani K, Gravanis A, et al. Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411683
BibTeX
@article{Papadopoulou2023,
author = {Papadopoulou, Maria Anna and Rogdakis, Thanasis and Charou, Despoina and Peteinareli, Maria and Ntarntani, Katerina and Gravanis, Achille and Chanoumidou, Konstantina and Charalampopoulos, Ioannis},
title = {Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241411683}
}
EUVIMED